GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (OTCPK:PSYBF) » Definitions » Pre-Tax Income

PsyBio Therapeutics (PsyBio Therapeutics) Pre-Tax Income : $-2.86 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. PsyBio Therapeutics's pretax income for the three months ended in Jun. 2023 was $-0.18 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $-2.86 Mil. PsyBio Therapeutics's pretax margin was %.


PsyBio Therapeutics Pre-Tax Income Historical Data

The historical data trend for PsyBio Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics Pre-Tax Income Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Pre-Tax Income
-11.02 -4.89

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.44 -0.92 -0.94 -0.81 -0.18

Competitive Comparison of PsyBio Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, PsyBio Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PsyBio Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's Pre-Tax Income falls into.



PsyBio Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

PsyBio Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.756+-0.109+-0.021+0+0
=-4.89

PsyBio Therapeutics's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.157+-0.025+0+0+0
=-0.18

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PsyBio Therapeutics  (OTCPK:PSYBF) Pre-Tax Income Explanation

PsyBio Therapeutics's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.182/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PsyBio Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


PsyBio Therapeutics (PsyBio Therapeutics) Business Description

Traded in Other Exchanges
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (PsyBio Therapeutics) Headlines